Program
19:30 - 20:15 | Elaine Fuchs, PhD
Rebecca C. Lancefield Professor; Investigator, Howard Hughes Medical Institute
20:15 - 21:00 | Michael Rosen, PhD
Chair, Department of Biophysics, UT Southwestern Medical Center; Investigator, Howard Hughes Medical Institute
21:00 - 21:15 | Short talk # 1. Dr. Christine Wu
MOHCCN Patient Working Group member
21:15 - 21:30 | Short talk # 2. Ms. Jennifer Coish
MOHCCN Patient Working Group member
10:30 – 11:00 | Morag Park, PhD
Professor, Department of Biochemistry and Director, Rosalind and Morris Goodman Cancer Centre, McGill University / Speaker supported by TFRI/MOHCCN
11:00 – 11:30 | Poul Sorensen, MD, PhD
Professor, Pathology, Department of Pediatrics and Urologic Sciences, University of British Columbia
11:30 - 11:45 | Short talk # 3 - Ryujhin Ahn
MIT, USA / CRS Next Generation of Scientists (NGS) Awardee
11:45 - 12:00 | Short talk # 4 - Claudia Gentile
Dana-Farber Cancer Institute, Harvard, USA / Dana-Farber Cancer Institute / Harvard, USA
8:30 – 9:00 | Frederick Dick, PhD
Professor of Pathology and Oncology, Western University
9:00 – 9:30 | Rama Khokha, PhD
Senior Scientist at the Princess Margaret Cancer Centre (PM), University Health Network
9:30 – 10:00 | Jean-François Côté, PhD
Director, Cytoskeletal Organization and Cell Migration Research Unit, IRCM; Full research professor, Department of Medicine, Université de Montréal
19:00 – 19:30 | David Hipfner, PhD
Director, Epithelial Cell Biology Research Unit, IRCM; Associate Research Professor, Department of Medicine (accreditation in molecular biology), Université de Montréal
19:30 – 20:00 | Costin Antonescu, PhD
Professor and Chair, Department of Chemistry and Biology, Toronto Metropolitan University
20:30 – 21:00 | Spencer Freeman, PhD
Assistant Professor, Department of Biochemistry, University of Toronto
21:00 – 21:30 | Philippe Roux, PhD
Principal Investigator, Cellular Signaling and Proteomics Research Unit, IRIC; Full Professor, Department of Pathology and Cell Biology, Faculty of Medicine, Université de Montréal
8:30 – 9:00 | Matthew J. Smith, PhD
Principal Investigator, Institute for Research in Immunology and Cancer (IRIC) Research Associate Professor, Department of Pathology and Cell Biology, Faculty of Medicine, Université de Montréal
9:00 – 9:30 | Nina Jones, PhD
Professor, Canada Research Chair Department of Molecular and Cellular Biology, University of Guelph
9:30 – 10:00 | James Murphy, PhD
Professor, Head, Inflammation Division, Walter and Eliza Hall Institute of Medical Research, Australia
10:30 – 11:00 | André Veillette, MD
Director, Molecular Oncology Research Unit, IRCM; Executive Director, Marathon of Hope Cancer Centres Network; Tier 1 Canada Research Chair in Immune System Signalling / Speaker supported by TFRI/MOHCCN
11:00 – 11:30 | Anne-Claude Gingras, PhD
Senior Investigator, Lunenfeld-Tanenbaum Research Institute
19:00 – 19:30 | Amélie Fradet-Turcotte, PhD
Full Professor, Department of Molecular Biology, Medical Biochemistry, and Pathology, Faculty of Medicine, Laval University; Researcher at the CHU de Québec Research Centre – Université Laval
19:30 – 20:00 | Lisa Porter, PhD
Distinguished Professor, University of Windsor; VP Research & Scientific Director, St Joseph’s Health Care London / Speaker supported by TFRI/MOHCCN
20:30 – 21:00 | Jean-Yves Masson, PhD
Centre de recherche du CHU de Québec-Université Laval, axe Oncologie: département de biologie moléculaire, biochimie médicale et pathologie de la Faculté de médecine de l’Université Laval / Speaker supported by TFRI/MOHCCN
21:00 – 21:30 | Peter Stirling, PhD
Associate Professor, Department of Medical Genetics, Faculty of Medicine, UBC; Scientist, BC Cancer Research Centre (BCCRC)
8:00 – 8:30 | Sonia del Rincón, PhD
Assistant Professor – Department of Oncology, McGill University. Associate Member - Department of Medicine, McGill University
8:30 – 9:00 | Sheila Singh, MD PhD FRCS(C)
Professor and Head, Neurosurgery & Professor of Biochemistry and Biomedical Sciences, McMaster University
9:00 – 9:30 | William Muller, PhD
Chair in Molecular Oncology, Fellow of Royal Society of Canada, Professor, Department of Biochemistry, Faculty of Medicine, McGill University
10:00 – 10:30 | Robert Rottapel
Professor, Departments of Medicine, Immunology and Medical Biophysics, University of Toronto; Senior Investigator, OICR; Co-Leader, Ovarian Cancer Translational Research Initiative; Senior Scientist and Amgen Chair for Cancer Research, Princess Margaret Cancer Centre / Speaker supported by TFRI/MOHCCN
10:30 – 11:00 | Sherri Christian, PhD
Professor, Department of Biochemistry, Memorial University; Cross-appointed, Biology and Faculty of Medicine / Speaker supported by TFRI/MOHCCN
11:00 – 11:30 | Shoukat Dedhar, PhD
Professor, Biochemistry and Molecular Biology; Professor, Genetics Graduate Program; Senior Scientist, British Columbia Cancer Agency / British Columbia Cancer Research Centre
13:00 – 13:30 | John Bell, PhD
Senior Scientist, Cancer Research Ottawa Hospital Research Institute ; Professor, Depts. of Medicine and Biochemistry, Microbiology & Immunology / Speaker supported by TFRI/MOHCCN
13:30 – 14:00 | Linda Penn, PhD
Senior Scientist, Princess Margaret; Tier 1 Canada Research Chair / Speaker supported by TFRI/MOHCCN
14:00 – 14:30 | Jeroen Roose, PhD
Principal Investigator and Vice Chair, Department of Anatomy, University of California, San Francisco (UCSF) - USA / Speaker supported by TFRI/MOHCCN
14:30 – 15:00 | Ramnik Xavier, MD, PhD
Kurt J. Isselbacher Professor of Medicine in the Field of Gastroenterology, Harvard Medical School / / Speaker supported by TFRI/MOHCCN
Rosalie Sears, PhD
Professor, Molecular and Medical Genetics, School of Medicine; Co-Director, Brenden-Colson Center for Pancreatic Care, School of Medicine; Krista L. Lake Chair in Cancer Research, Oregon Health & Science University (OHSU) - USA / Speaker supported by TFRI/MOHCCN
